(Q36835915)

English

Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial

scientific article published on September 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial (English)

1 reference

Europe PubMed Central

16 August 2017

0 references

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

Lubsen J

1

1 reference

Europe PubMed Central

16 August 2017

Just H

2

1 reference

Europe PubMed Central

16 August 2017

Hjalmarsson AC

3

1 reference

Europe PubMed Central

16 August 2017

La Framboise D

4

1 reference

Europe PubMed Central

16 August 2017

Remme WJ

5

1 reference

Europe PubMed Central

16 August 2017

Heinrich-Nols J

6

1 reference

Europe PubMed Central

16 August 2017

Dumont JM

7

1 reference

Europe PubMed Central

16 August 2017

Seed P

8

1 reference

Europe PubMed Central

16 August 2017

language of work or name

0 references

publication date

1 September 1996

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

76

1 reference

Europe PubMed Central

16 August 2017

3

1 reference

Europe PubMed Central

16 August 2017

223-231

1 reference

Europe PubMed Central

16 August 2017

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484511

29 September 2017

Calcium sensitization with pimobendan: pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484511

29 September 2017

Classification of positive inotropic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484511

29 September 2017

Inotropic support of the critically ill patient. A review of the agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484511

29 September 2017

New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484511

29 September 2017

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484511

29 September 2017

Clinical effects of long-term administration of pimobendan in patients with moderate congestive heart failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484511

5 September 2018

Exercise testing as outcome in congestive heart failure trials. Design considerations when interpreting results

1 reference

https://pubmed.ncbi.nlm.nih.gov/8868980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy and safety of pimobendan in moderate heart failure. A double-blind parallel 6-month comparison with enalapril. The Pimobendan-Enalapril Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8868980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Charts of the power function for analysis of variance tests, derived from the non-central F-distribution

1 reference

https://pubmed.ncbi.nlm.nih.gov/8868980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of a frequency definition of ventricular proarrhythmia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8868980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8868980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8868980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/8868980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8868980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HRT.76.3.223

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36835915&oldid=2150674359"